Automated peritoneal dialysis: New implications for pharmacists

Annals of Pharmacotherapy

Volumn 31, Issue 6, 1997, Pages 756-764

  Brophy, Donald F ^a   Mueller, Bruce A ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

End stage kidney failure; Peritoneal dialysis

Indexed keywords

AUTOMATION; DRUG BLOOD LEVEL; DRUG MONITORING; HUMAN; KIDNEY FAILURE; PERITONEAL DIALYSIS; PHARMACY; PRIORITY JOURNAL; REVIEW;

EID: 0030917189     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100616     Document Type: Review

References (47)

1. US Renal Data Systems. USRDS 1995 annual data report. Bethesda, MD: The National Institutes of Health, Institute of Diabetes and Digestive and Kidney Diseases, April 1995.
2. Rippe B, Krediet RT. Peritoneal physiology - transport of solutes. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht, Netherlands: Kluwer Academic Publishers, 1994:69-113.
3. Khanna R, Nolph KD, Oreopolous DG. Physiology of peritoneal dialysis. In: The essentials of peritoneal dialysis. Dordrecht, Netherlands: Kluwer Academic Publishers, 1993:1-18.
4. Ronco C, Bosch JP, Lew SQ, Feriani M, Chiaramonte S, Conz P, et al. Adequacy of continuous ambulatory peritoneal dialysis: comparison with other dialysis techniques. Kidney Int 1994;46(suppl 48):S18-24.
5. Keshaviah P. Technological aspects of hemodialysis and peritoneal dialysis. In: Nissenson AR, Fine RN, Gentile DE, eds. Clinical dialysis. 3rd ed. Norwalk, CT: Appleton and Lange, 1995:46-76.
6. Diaz-Buxo JA. CCPD is even better than CAPD. Kidney Int 1985;28 (suppl 17):S26-8.
7. Khanna R, Nolph KD, Oreopolous DG. Techniques, prescriptions, and indications. In: The essentials of peritoneal dialysis. Dordrecht, Netherlands: Kluwer Academic Publishers, 1993:35-44.
8. Nolph KD, Lindblad AS, Novak JW. Continuous ambulatory peritoneal dialysis. N Engl J Med 1988;318:1595-600.
9. Kiley JE. Neurological aspects of dialysis. In: Nissenson AR, Fine RN, Gentile DE, eds. Clinical dialysis. 2nd ed. Norwalk, CT: Appleton and Lange, 1990:535-53.
10. Kabanda A, Goffm E, Bernard A, Lauwerys R, Van Yperseke De Strihou C. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int 1995;48:1946-52.
11. Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA. Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int 1992;42:967-71.
12. Maiorca R, Cancarini GC, Brunori G, Camerini C, Manili L. Morbidity and mortality of CAPD and hemodialysis. Kidney Int 1993;43(suppl 40):S4-15.
13. Khanna R, Nolph KD, Oreopolous DG. Peritonitis and exit-site infections. In: The essentials of peritoneal dialysis. Dordrecht, Netherlands: Kluwer Academic Publishers, 1993:76-88.
14. Woodrow G, Turney JH, Cook JA, Gibson J, Fletcher S, Stewart AJ, et al. Nocturnal intermittent peritoneal dialysis. Nephrol Dial Transplant 1994;9:399-403.
15. Domoto DT, Weindel ME. Continuous cyclic peritoneal dialysis - is it worth the extra effort? Adv Perit Dial 1989;5:212-5.
16. Diaz-Buxo JA, Suki WN. Automated peritoneal dialysis. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht, Netherlands: Kluwer Academic Publishers, 1994:399-418.
17. Diaz-Buxo JA. Automated peritoneal dialysis therapies - patient selection and dialysis prescription. Adv Perit Dial 1989;5:207-11.
18. Twardowski ZJ. Nightly peritoneal dialysis. Why, who, how and when? ASAIO Trans 1990;36:8-16.
19. Howdieshell TR, Blalock WE, Bowen PA, Hawkins ML, Hess C. Management of post-traumatic acute renal failure with peritoneal dialysis. Am Surg 1992;58:378-82.
20. Khanna R, Nolph KD, Oreopolous DG. Automated peritoneal dialysis. In: The essentials of peritoneal dialysis. Dordrecht, Netherlands: Kluwer Academic Publishers, 1993:64-8.
21. Twardowski Z, Ksiazek A, Majdan M, Janicka L, Bochenska-Nowacka E, Sokolowska G, et al. Kinetics of continuous ambulatory peritoneal dialysis (CAPD) with four exchanges per day. Clin Nephrol 1981;15: 119-30.
22. Paton TW, Cornish WR, Manuel MA, Hardy BG. Drug therapy in patients undergoing peritoneal dialysis. Clin Pharmacokinet 1985;10:404-26.
23. Matzke GR, Millikin SP. Influence of renal function and dialysis on drug disposition. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetics. Vancouver, WA: Applied Therapeutics, Inc., 1992:15-1-15-31.
24. Bennett WM, Aronoff GR, Golper TA, Morrison G, Brater DC, Singer I. Drug prescribing in renal failure. Philadelphia: American College of Physicians, 1994.
25. Keane WF, Alexander SR, Bailie GR, Boeschoten E, Golper TA, Holmes CJ, et al. Peritoneal dialysis related peritonitis treatment recommendations. 1996 update. Perit Dial Int 1996;16:557-73.
26. Bailie GR, Eisele G. Pharmacokinetic issues in treatment of CAPD peritonitis. J Antimicrob Chemother 1995;35:563-7.
27. Bunke CM, Aronoff GR, Brier ME, Sloan RS, Luft FC. Vancomycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983;34:631-7.
28. Pancorbo S, Comty C. Peritoneal transport of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis. Nephron 1982;31: 37-9.
29. Morse GD, Farolino DF, Apicella MA, Walshe JJ. Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1987;31:173-7.
30. Neal D, Bailie GR. Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis. Clin Pharmacokinet 1990;18:485-90.
31. Singlas E, Colin JN, Rottembourg J, Meesem JP, de Martin A, Simon P. Pharmacokinetics of sulfamethoxazole-trimethoprim combination during chronic peritoneal dialysis: effects of peritonitis. Eur J Clin Pharmacol 1982;21:409-15.
32. Somani P, Shapiro RS, Stockard H, Higgins JT. Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1982;32:113-21.
33. Local FK, Munro AJ, Derr DNS, Sussman M. Pharmacokinetics of intravenous and intraperitoneal cefuroxime in patients undergoing peritoneal dialysis. Clin Nephrol 1981;16:40-3.
34. Gross ML, Somani P, Ribner BS, Raeader R, Freimer EH, Higgins JT. Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983;34:673-80.
35. O'Brien MA, Mason NA. Systemic absorption of intraperitoneal antimicrobials in continuous ambulatory peritoneal dialysis. Clin Pharm 1992; 11:246-54.
36. Hirszel P, Lameire N, Bogaert M. Pharmacologic alterations of peritoneal transport rates and pharmacokinetics of the peritoneum. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht, Netherlands: Kluwer Academic Publishers, 1994:161-232.
37. Keller E, Reetze P, Schollmeyer P. Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis: clinical pharmacokinetic considerations. Clin Pharmacokinet 1990;18:104-17.
38. Clark W, Scott M, Mueller B, Kraus M, Macias W. Mass transfer characterization of vancomycin removal by high-flux cellulosic membranes (abstract). J Am Soc Nephrol 1995;6:486.
39. Rogge MC, Johnson CA, Zimmerman SW, Welling PG. Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport. Antimicrob Agents Chemother 1985;27:578-82.
40. Nielsen HE, Sorensen I, Hansen HE. Peritoneal transport of vancomycin during peritoneal dialysis. Nephron 1979;24:274-7.
41. Glew RH, Pavuk RA, Shuster A, Alfred HJ. Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis. Int J Clin Pharm Ther Tox 1982;20:559-63.
42. Mulhern JG, Braden GL, O'Shea MH, Madden RL, Lipkowitz GS, Germain MJ. Trough serum vancomycin levels predict the relapse of grampositive peritonitis in peritoneal dialysis patients. Am J Kidney Dis 1995; 25:611-5.
43. Jusko WJ, Baliah T, Kim KH, Gerbracht LM, Yaffe SJ. Pharmacokinetics of gentamicin during peritoneal dialysis in children. Kidney Int 1976; 9:430-8.
44. Bunke CM, Aronoff GR, Brier ME, Sloan RS, Luft FC. Tobramycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983;34:110-6.
45. Morse GD, Apicella MA, Walshe JJ. Absorption of intraperitoneal antibiotics. Drug Intell Clin Pharm 1988;22:58-61.
46. Harford AM, Sica DA, Tartaglione T, Polk RE, Dalton HP, Poynor W. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis. Nephron 1986;43:217-22.
47. Hirata-Dulas CA. Dialytic treatment modalities. In: Carter BA, Angaran DM, Lake KD, Raebel MA, eds. Pharmacotherapy self-assessment program II. Kansas City: American College of Clinical Pharmacy, 1996: 161-81.